XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business segment information
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Business segment information

9. Business segment information

The table below present net sales, which includes product sales and marketing service fees, by reporting segment:

 

 

 

Three Months Ended June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

Change

 

BioStim

 

$

48,211

 

 

$

47,174

 

 

 

2.2

%

Spine Fixation

 

 

23,880

 

 

 

21,360

 

 

 

11.8

%

Biologics

 

 

14,668

 

 

 

15,661

 

 

 

-6.3

%

Extremity Fixation

 

 

24,788

 

 

 

24,747

 

 

 

0.2

%

Net sales

 

$

111,547

 

 

$

108,942

 

 

 

2.4

%

 

 

 

 

Six Months Ended June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

Change

 

BioStim

 

$

94,374

 

 

$

91,713

 

 

 

2.9

%

Spine Fixation

 

 

44,587

 

 

 

40,627

 

 

 

9.7

%

Biologics

 

 

29,003

 

 

 

30,648

 

 

 

-5.4

%

Extremity Fixation

 

 

52,292

 

 

 

48,692

 

 

 

7.4

%

Net sales

 

$

220,256

 

 

$

211,680

 

 

 

4.1

%

The primary metric used in managing the Company is non-GAAP net margin, which is an internal metric that the Company defines as gross profit less sales and marketing expense. The table below presents non-GAAP net margin by reporting segment:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

BioStim

 

$

21,298

 

 

$

19,469

 

 

$

40,244

 

 

$

36,602

 

Spine Fixation

 

 

2,887

 

 

 

2,696

 

 

 

4,148

 

 

 

4,703

 

Biologics

 

 

6,247

 

 

 

6,470

 

 

 

12,327

 

 

 

12,641

 

Extremity Fixation

 

 

7,002

 

 

 

6,766

 

 

 

15,160

 

 

 

13,178

 

Corporate

 

 

(251

)

 

 

(107

)

 

 

(402

)

 

 

(205

)

Non-GAAP net margin

 

$

37,183

 

 

$

35,294

 

 

$

71,477

 

 

$

66,919

 

General and administrative

 

 

22,268

 

 

 

20,409

 

 

 

41,752

 

 

 

38,691

 

Research and development

 

 

7,891

 

 

 

6,887

 

 

 

14,828

 

 

 

14,311

 

Operating income

 

$

7,024

 

 

$

7,998

 

 

$

14,897

 

 

$

13,917

 

Interest income (expense), net

 

 

(251

)

 

 

76

 

 

 

(434

)

 

 

121

 

Other income (expense), net

 

 

(4,752

)

 

 

585

 

 

 

(1,840

)

 

 

(3,763

)

Income before income taxes

 

$

2,021

 

 

$

8,659

 

 

$

12,623

 

 

$

10,275

 

 

Geographical information

The table below present net sales by geographic destination for each reporting unit and for the consolidated Company:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

BioStim

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

$

48,202

 

 

$

47,162

 

 

$

94,339

 

 

$

91,701

 

International

 

 

9

 

 

 

12

 

 

 

35

 

 

 

12

 

Total BioStim

 

 

48,211

 

 

 

47,174

 

 

 

94,374

 

 

 

91,713

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Spine Fixation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

18,853

 

 

 

18,050

 

 

 

36,432

 

 

 

34,085

 

International

 

 

5,027

 

 

 

3,310

 

 

 

8,155

 

 

 

6,542

 

Total Spine Fixation

 

 

23,880

 

 

 

21,360

 

 

 

44,587

 

 

 

40,627

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Biologics

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

14,667

 

 

 

15,651

 

 

 

28,989

 

 

 

30,614

 

International

 

 

1

 

 

 

10

 

 

 

14

 

 

 

34

 

Total Biologics

 

 

14,668

 

 

 

15,661

 

 

 

29,003

 

 

 

30,648

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Extremity Fixation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

7,023

 

 

 

6,741

 

 

 

13,939

 

 

 

13,320

 

International

 

 

17,765

 

 

 

18,006

 

 

 

38,353

 

 

 

35,372

 

Total Extremity Fixation

 

 

24,788

 

 

 

24,747

 

 

 

52,292

 

 

 

48,692

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

88,745

 

 

 

87,604

 

 

 

173,699

 

 

 

169,720

 

International

 

 

22,802

 

 

 

21,338

 

 

 

46,557

 

 

 

41,960

 

Net sales

 

$

111,547

 

 

$

108,942

 

 

$

220,256

 

 

$

211,680